Anti-C Reactive Protein antibody [Y284] (ab32412)

Publishing research using ab32412? Please let us know so that we can cite the reference in this datasheet.

ab32412 has been referenced in 17 publications.

  • Garrido M  et al. C-reactive protein expression is up-regulated in apical lesions of endodontic origin in association with interleukin-6. J Endod 41:464-9 (2015). PubMed: 25748492
  • She S  et al. C-reactive protein is a biomarker of AFP-negative HBV-related hepatocellular carcinoma. Int J Oncol 47:543-54 (2015). PubMed: 26058824
  • Zhao C  et al. Early second-trimester plasma protein profiling using multiplexed isobaric tandem mass tag (TMT) labeling predicts gestational diabetes mellitus. Acta Diabetol 52:1103-12 (2015). WB ; Human . PubMed: 26259496
  • Ferreira R  et al. Comparative proteomic analyses of urine from rat urothelial carcinoma chemically induced by exposure to N-butyl-N-(4-hydroxybutyl)-nitrosamine. Mol Biosyst 11:1594-602 (2015). WB ; Rat . PubMed: 25739956
  • Moreira-Gonçalves D  et al. Signaling pathways underlying skeletal muscle wasting in experimental pulmonary arterial hypertension. Biochim Biophys Acta 1852:2722-31 (2015). WB ; Rat . PubMed: 26456917
  • Ezzelarab MB  et al. Systemic inflammation in xenograft recipients precedes activation of coagulation. Xenotransplantation N/A:N/A (2014). Baboon . PubMed: 25209710
  • Can C  et al. Prognostic impact of intratumoral C-reactive protein expression in patients with clear cell renal cell carcinoma. Urol Int 92:270-5 (2014). PubMed: 24356040
  • Joseph NM  et al. Diagnostic utility and limitations of glutamine synthetase and serum amyloid-associated protein immunohistochemistry in the distinction of focal nodular hyperplasia and inflammatory hepatocellular adenoma. Mod Pathol N/A:N/A (2013). PubMed: 23807780
  • Peng L  et al. Serum proteomics analysis and comparisons using iTRAQ in the progression of hepatitis B. Exp Ther Med 6:1169-1176 (2013). WB ; Human . PubMed: 24223640
  • Caseiro A  et al. Salivary proteome and peptidome profiling in type 1 diabetes mellitus using a quantitative approach. J Proteome Res 12:1700-9 (2013). WB ; Human . PubMed: 23406527
  • Arantes-Rodrigues R  et al. Meloxicam in the treatment of in vitro and in vivo models of urinary bladder cancer. Biomed Pharmacother 67:277-84 (2013). WB ; Mouse . PubMed: 23582791
  • Padrão AI  et al. Bladder cancer-induced skeletal muscle wasting: disclosing the role of mitochondria plasticity. Int J Biochem Cell Biol 45:1399-409 (2013). PubMed: 23608519
  • Prasad S  et al. Silicon Nanosensor for Diagnosis of Cardiovascular Proteomic Markers. J Lab Autom : (2012). Human . PubMed: 23015518
  • Ali S  et al. Expression of C-reactive protein and cyclooxygenase enzyme-2 in clear cell renal cell carcinoma: correlation with pathological parameters in 110 patients. Tumour Biol 32:375-80 (2011). IHC-P ; Human . PubMed: 21086092
  • Bhutto IA  et al. C-reactive protein and complement factor H in aged human eyes and eyes with age-related macular degeneration. Br J Ophthalmol 95:1323-30 (2011). IHC-Fr ; Human . PubMed: 21633121
  • Johnson TV  et al. Intratumor C-reactive protein as a biomarker of prognosis in localized renal cell carcinoma. J Urol 186:1213-7 (2011). IHC ; Human . PubMed: 21849188
  • Ortiz MA  et al. Continuously-infused human C-reactive protein is neither proatherosclerotic nor proinflammatory in apolipoprotein E-deficient mice. Exp Biol Med (Maywood) 234:624-31 (2009). PubMed: 19359657